AMGEN INC (AMGN) Stock Analyst Ratings
NASDAQ:AMGN • US0311621009
369.19 USD
+2.99 (+0.82%)
At close: Feb 13, 2026
369.15 USD
-0.04 (-0.01%)
After Hours: 2/13/2026, 9:53:06 PM
ChartMill assigns a Buy % Consensus number of 72% to AMGN. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 341.81. This target is -7.42% below the current price.
- AMGN was analyzed by 41 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about AMGN.
- In the previous month the buy percentage consensus was at a similar level.
- AMGN was analyzed by 41 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-06 | Guggenheim | Maintains | Neutral -> Neutral |
| 2026-02-06 | Argus Research | Maintains | Buy -> Buy |
| 2026-02-04 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2026-02-04 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2026-02-04 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-04 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-01-26 | UBS | Maintains | Buy -> Buy |
| 2026-01-20 | Bernstein | Downgrade | Outperform -> Market Perform |
| 2026-01-08 | Truist Securities | Maintains | Hold -> Hold |
| 2025-12-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-10 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-03 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-11-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-11-06 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2025-11-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-05 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-09-26 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-08-25 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-08-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-08-06 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-06 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-07-23 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-07-22 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-07-21 | UBS | Maintains | Neutral -> Neutral |
| 2025-06-27 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-06-24 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2025-05-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-07 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-05-02 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-02 | RBC Capital | Maintains | Outperform -> Outperform |
AMGEN INC / AMGN FAQ
What do analysts expect the price target to be for AMGEN INC (AMGN)?
41 analysts have analysed AMGN and the average price target is 341.81 USD. This implies a price decrease of -7.42% is expected in the next year compared to the current price of 369.19.
What is the consensus rating for AMGEN INC (AMGN) stock?
The consensus rating for AMGEN INC (AMGN) is 71.7073 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for AMGN stock?
The number of analysts covering AMGEN INC (AMGN) is 41.